Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -647.57% | -66,241.31% | -818.79% | -13.39% | 61.66% |
| Total Depreciation and Amortization | 27.86% | 16.32% | 15.55% | 20.60% | 25.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,878.36% | 856.16% | 928.16% | 262.50% | -115.05% |
| Change in Net Operating Assets | 92.17% | 142.64% | 32.73% | 93.04% | -72.48% |
| Cash from Operations | 19.51% | 30.63% | 31.39% | 28.40% | 18.09% |
| Capital Expenditure | 26.81% | 70.72% | 71.15% | 90.52% | 93.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 26.81% | 70.72% | 71.15% | 90.50% | 93.20% |
| Total Debt Issued | 300.00% | 50.00% | -28.34% | -28.34% | -83.25% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1,447.73% | 406.15% | -100.00% | -100.00% |
| Repurchase of Common Stock | -26.67% | -26.67% | 24.59% | 55.77% | -74.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 344.82% | 62.46% | -26.73% | -28.53% | -83.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 182.80% | 68.76% | 84.50% | 65.44% | -261.70% |